Learn more

CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCES

Overview
  • Total Patents
    28
  • GoodIP Patent Rank
    133,265
About

CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCES has a total of 28 patent applications. Its first patent ever was published in 2007. It filed its patents most often in China. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are PILOTS POINT LLC, RAPID LAB MICROSYSTEMS INC and GENESEQUE AS.

Patent filings in countries

World map showing CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCESs patent filings in countries
# Country Total Patents
#1 China 28

Patent filings per year

Chart showing CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCESs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 He Jie 8
#2 Chen Zhaoli 8
#3 Han Xiaohong 3
#4 Ma Fei 3
#5 Sun Nan 3
#6 Shi Yuankai 3
#7 Xu Binghe 3
#8 Tan Fengwei 3
#9 Ou Yunwei 2
#10 Zhou Chengcheng 2

Latest patents

Publication Filing date Title
CN104818322A Use of miRNA-Cyfra21-1 combination in detection of non-small cell lung cancer
CN104391114A ELISA method for quantitatively determining concentration of recombinant human-mouse chimeric anti-CD20 monoclonal antibody in human blood serum
CN104337803A Application of xerophilusin B in preparation of products for inhibiting tumor growth
CN104152556A Kit for judging adjunctive therapeutic effects of trastuzumab on breast cancer and application
CN104131101A Reagent for detecting SNP sites of P53 genes and application of reagent
CN104120188A Hand-foot syndrome susceptibility detection kit and application of SNP in preparation of detection kit
CN104111332A Kit applied to auxiliary diagnosis of patients with non-small cell lung cancer based on protein marker PAK4
CN105002139A Method for promoting proliferation of NK cell by using CD3+CD8+CD56+T cell subtype
CN104873984A Use of microRNA-548k inhibitor in treatment and/or prevention of esophageal squamous cancer
CN104873973A Use of FAM135B inhibitor in treatment and/or prevention of esophageal squamous cancer
CN103739664A Methods for separating and identifying DNA (deoxyribonucleic acid) binding protein through DNA co-immunoprecipitation
CN104807996A Uses of cell surface marker molecule in detection of liver cancer circulating tumor cells
CN104762368A Kit used for aided prediction on postoperative survival time of esophageal squamous cell carcinoma patients
CN103529160A UPLC-MS/MS method for determination of simotinib concentration in human blood plasma
CN103454360A Ultrafiltration and UPLC-MS/MS (ultra-high performance liquid chromatography tandem mass spectrometry) method for measuring concentration of free docetaxel in human plasma
CN104422777A Application of ANO1 protein in prediction on prognosis of esophagus cancer and precancerous lesion risk
CN103243161A Product for performing assisted prediction on postoperative survival time length of esophageal squamous carcinoma patient
CN103091341A Detection method for radiosensitivity of solid tumor cell
CN103013924A Solid tumor tissue digestive juice
CN103566369A Hepatitis B vaccine for inducing organism to generate specific immunity in state of chronic hepatitis B virus infection